/
you're reading...

Stonehaven Incubate launches new company aiming to tackle canine osteoarthritis

Stonehaven Incubate has partnered with human health player Regenosine to launch Vetosine, a new company that will develop and commercialize a first-in-class disease modifying osteoarthritis drug (DMOA...

Read full story

Archives